341 related articles for article (PubMed ID: 19798727)
1. Recombinant C1 inhibitor in brain ischemic injury.
Gesuete R; Storini C; Fantin A; Stravalaci M; Zanier ER; Orsini F; Vietsch H; Mannesse ML; Ziere B; Gobbi M; De Simoni MG
Ann Neurol; 2009 Sep; 66(3):332-42. PubMed ID: 19798727
[TBL] [Abstract][Full Text] [Related]
2. Effects of C1 inhibitor on tissue damage in a porcine model of controlled hemorrhage.
Dalle Lucca JJ; Li Y; Simovic M; Pusateri AE; Falabella M; Dubick MA; Tsokos GC
Shock; 2012 Jul; 38(1):82-91. PubMed ID: 22683724
[TBL] [Abstract][Full Text] [Related]
3. Effect of supraphysiologic levels of C1-inhibitor on the classical, lectin and alternative pathways of complement.
Nielsen EW; Waage C; Fure H; Brekke OL; Sfyroera G; Lambris JD; Mollnes TE
Mol Immunol; 2007 Mar; 44(8):1819-26. PubMed ID: 17101176
[TBL] [Abstract][Full Text] [Related]
4. C1-inhibitor attenuates neurobehavioral deficits and reduces contusion volume after controlled cortical impact brain injury in mice.
Longhi L; Perego C; Ortolano F; Zanier ER; Bianchi P; Stocchetti N; McIntosh TK; De Simoni MG
Crit Care Med; 2009 Feb; 37(2):659-65. PubMed ID: 19114897
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study.
Moldovan D; Reshef A; Fabiani J; Kivity S; Toubi E; Shlesinger M; Triggiani M; Montinaro V; Cillari E; Realdi G; Cancian M; Visscher S; Zanichelli A; Relan A; Cicardi M
Clin Exp Allergy; 2012 Jun; 42(6):929-35. PubMed ID: 22909164
[TBL] [Abstract][Full Text] [Related]
6. C1, MBL-MASPs and C1-inhibitor: novel approaches for targeting complement-mediated inflammation.
Beinrohr L; Dobó J; Závodszky P; Gál P
Trends Mol Med; 2008 Dec; 14(12):511-21. PubMed ID: 18977695
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of complement activation and effects of C1-inhibitor on the meconium-induced inflammatory reaction in human cord blood.
Salvesen B; Nielsen EW; Harboe M; Saugstad OD; Mollnes TE
Mol Immunol; 2009 Feb; 46(4):688-94. PubMed ID: 18950866
[TBL] [Abstract][Full Text] [Related]
8. C1-inhibitor protects against brain ischemia-reperfusion injury via inhibition of cell recruitment and inflammation.
Storini C; Rossi E; Marrella V; Distaso M; Veerhuis R; Vergani C; Bergamaschini L; De Simoni MG
Neurobiol Dis; 2005; 19(1-2):10-7. PubMed ID: 15837556
[TBL] [Abstract][Full Text] [Related]
9. C1 inhibitor treatment improves host defense in pneumococcal meningitis in rats and mice.
Zwijnenburg PJ; van der Poll T; Florquin S; Polfliet MM; van den Berg TK; Dijkstra CD; Roord JJ; Hack CE; van Furth AM
J Infect Dis; 2007 Jul; 196(1):115-23. PubMed ID: 17538891
[TBL] [Abstract][Full Text] [Related]
10. Plasma-derived mannose-binding lectin shows a direct interaction with C1-inhibitor.
Keizer MP; Kamp AM; Brouwer N; van de Wetering MD; Wouters D; Kuijpers TW
Mol Immunol; 2014 Apr; 58(2):187-93. PubMed ID: 24368318
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of recombinant human C1 esterase inhibitor for the treatment of severe hereditary angioedema attacks.
Li HH; Reshef A; Baker JW; Harper JR; Relan A
Allergy Asthma Proc; 2017 Nov; 38(6):456-461. PubMed ID: 28874235
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human C1 esterase inhibitor for acute hereditary angioedema attacks with upper airway involvement.
Riedl MA; Li HH; Cicardi M; Harper JR; Relan A
Allergy Asthma Proc; 2017 Nov; 38(6):462-466. PubMed ID: 28903805
[TBL] [Abstract][Full Text] [Related]
13. The powerful neuroprotective action of C1-inhibitor on brain ischemia-reperfusion injury does not require C1q.
De Simoni MG; Rossi E; Storini C; Pizzimenti S; Echart C; Bergamaschini L
Am J Pathol; 2004 May; 164(5):1857-63. PubMed ID: 15111332
[TBL] [Abstract][Full Text] [Related]
14. Recombinant Human C1-Esterase Inhibitor to Treat Acute Hereditary Angioedema Attacks in Adolescents.
Baker JW; Reshef A; Moldovan D; Harper JR; Relan A; Riedl MA
J Allergy Clin Immunol Pract; 2017; 5(4):1091-1097. PubMed ID: 28202404
[TBL] [Abstract][Full Text] [Related]
15. Home treatment of attacks with conestat alfa in hereditary angioedema due to C1-inhibitor deficiency.
Farkas H; Csuka D; Veszeli N; Zotter Z; Szabó E; Varga L
Allergy Asthma Proc; 2014; 35(3):255-9. PubMed ID: 24801469
[TBL] [Abstract][Full Text] [Related]
16. Complement factor 1 inhibitor improves cardiopulmonary function in neonatal cardiopulmonary bypass.
Baig K; Nassar R; Craig DM; Quick G; Jiang HX; Frank MM; Lodge AJ; Anderson PA; Jaggers J
Ann Thorac Surg; 2007 Apr; 83(4):1477-82; discussion 1483. PubMed ID: 17383361
[TBL] [Abstract][Full Text] [Related]
17. Combination Therapy with Low-Dose IVIG and a C1-esterase Inhibitor Ameliorates Brain Damage and Functional Deficits in Experimental Ischemic Stroke.
Chen X; Arumugam TV; Cheng YL; Lee JH; Chigurupati S; Mattson MP; Basta M
Neuromolecular Med; 2018 Mar; 20(1):63-72. PubMed ID: 29299869
[TBL] [Abstract][Full Text] [Related]
18. C1-INH and its effect on infarct size and ventricular function in an acute pig model of infarction, cardiopulmonary bypass, and reperfusion.
Schreiber C; Heimisch W; Schad H; Brkic A; Badiu C; Lange R; Bauernschmitt R
Thorac Cardiovasc Surg; 2006 Jun; 54(4):227-32. PubMed ID: 16755442
[TBL] [Abstract][Full Text] [Related]
19. C1-esterase inhibitor protects against neointima formation after arterial injury in atherosclerosis-prone mice.
Shagdarsuren E; Bidzhekov K; Djalali-Talab Y; Liehn EA; Hristov M; Matthijsen RA; Buurman WA; Zernecke A; Weber C
Circulation; 2008 Jan; 117(1):70-8. PubMed ID: 18071075
[TBL] [Abstract][Full Text] [Related]
20. A novel measurement method for activation of the lectin complement pathway via both mannose-binding lectin (MBL) and L-ficolin.
Inoshita H; Matsushita M; Koide S; Kusaba G; Ishii M; Onda K; Gi MJ; Nakata M; Ohsawa I; Horikoshi S; Ohi H; Tomino Y
J Immunol Methods; 2009 Sep; 349(1-2):9-17. PubMed ID: 19699205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
